CClinicalTrials.gg
CompletedNCT01477255DIARY1Updated Apr 8, 2016

The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population

An observational study in Cancer, sponsored by St. Jude Children's Research Hospital. Completed at 1 site in United States. Open to participants aged 8 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-08.

Sponsored by St. Jude Children's Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
154
Ages
8 Years to 17 Years
Sex
All
01

Study summary

This investigation seeks to determine the feasibility of an electronic diary methodology among pediatric cancer patients and healthy matched controls. Levels of study participation and compliance will be assessed to assist with determining overall feasibility. Results will offer insight into the effectiveness of this means of data collection with a pediatric oncology population, and will examine how psychosocial and contextual factors contribute to the resiliency that has been demonstrated by children with cancer. Findings will provide data for the design and implementation of a future, larger-scale study with this pediatric population that implements an electronic daily diary methodology.

Read the detailed description

The study will include two phases of participant recruitment and participation. Phase I will include recruitment of six pediatric patients to pilot an electronic daily diary on an Apple iPad. These participants will be prompted by the iPad once daily for seven days, and will be asked to answer multiple choice and yes/no questions related to their daily experiences, activities and emotions. Following the week of daily diary completion, each participant in Phase I will engage in a brief feedback interview with a member of the research team to discuss his/her overall experiences using the electronic diary, including any technological issues that arise. The purpose of Phase I is to work out any technological and/or logistical problems associated with completion of the daily iPad diary.

After any technological problems have been addressed, Phase II of the study will begin. Child participants in Phase II of the study will complete several paper and pencil questionnaires on two separate occasions that assess factors including optimism, experience of various emotions, spirituality, relationships with others, benefit-finding, quality of life, and resiliency. Children will also complete two weeks of daily electronic diaries that will prompt them to answer multiple choice and yes/no questions related to their daily experiences, activities and emotions. One parent or guardian will also be recruited to participate, and will complete paper and pencil questionnaires on two separate occasions that ask about optimism, the parent-child relationship, spirituality, psychological functioning, and their perceptions of their children's behavior and mood.

Finally, following the completion of the first week of daily diaries, a short interview will be conducted with each child and parent dyad to gather information about the child's experiences using the electronic diary. They will be asked to provide feedback about any challenges and technological difficulties that they encountered, as well as their general thoughts about using the electronic diary. The interview will also include an opportunity to trouble-shoot difficulties associated with using the electronic daily diary in preparation for the second week of diary completion. For each participant, we anticipate a participation timeframe of 10-15 weeks.

Primary Objective:

  • To evaluate the usefulness of an electronic daily diary for understanding the experiences, emotions, and coping strategies of children with cancer and of their healthy peers.
02

Conditions studied

  • Cancer

Keywords

  • daily assessment
  • electronic diary
  • coping strategies
  • resiliency of cancer patients
  • psychology
03

In context

Lead sponsor

St. Jude Children's Research Hospital is the lead sponsor of 434 studies on the registry; 99 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 35 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All eligible participants will be invited to participate in the research investigation, including children and parents of both genders and of all races/ethnicities.

St. Jude treats pediatric patients from across the country and around the world, which results in a culturally diverse pediatric population. Based upon enrollment patterns from previous investigations, it is anticipated that approximately 19% of enrolled pediatric participants will be racial/ethnic minority children. Because the control group will be matched to the pediatric group on variables of gender, age, race/ethnicity, and socioeconomic status, it is anticipated that the gender and race/ethnicity of the control group will be commensurate with that of the pediatric group.

Eligibility criteria

Inclusion Criteria for Pediatric Participants:

  • Research participant is between ages 8 and 17 years inclusive.
  • Research participant has received a diagnosis of malignancy in the period 10 weeks prior to enrollment.
  • Research participant has no significant cognitive, motor, or sensory deficits that would preclude completion of the study measures.
  • Research participant is able to speak and read English.

Inclusion Criteria for Control Participants:

  • Research participant is between ages 8 and 17 years inclusive.
  • Research participant has no history of a major medical diagnosis.
  • Research participant has no significant cognitive, motor, or sensory deficits that would preclude completion of the study measures.
  • Research participant is able to speak and read English.

Exclusion Criteria:

  • Participants are excluded if they fail to meet any of the Inclusion Criteria for Pediatric or Control Participants.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
154 participants (actual)

Groups and cohorts

  • Cancer patient

    Patient participants will include children and adolescents between the ages of 8-17 years who have been recently diagnosed with cancer. They will use an iPad as a diary to track their daily experiences. They will use an iPad as a diary to track their daily experiences.

    Behavioral: iPad

  • Control

    For each pediatric patient enrolled, a child without a history of a serious medical illness will be recruited from the larger community who is matched on variables of age, race/ethnicity, gender, and socioeconomic status. They will use an iPad as a diary to track their daily experiences. They will use an iPad as a diary to track their daily experiences.

    Behavioral: iPad

Interventions

  • BehavioraliPad

    The proposed investigation is a prospective case-control pilot study. The major goal of this pilot study is to assess the feasibility of a daily diary methodology for monitoring the experiences of recently diagnosed pediatric cancer patients and healthy-matched peers. The investigation will also examine the relationships among individual and contextual factors that influence the daily psychosocial functioning of youth with cancer in comparison to youth without cancer.

    Also known as: electronic diary

06

What researchers measure

Primary outcomes

  1. The number who agree to participate compared to the total number approached for the study.

    The rate of agreement to participate in the study.

    Time frame: Day 0 of study

  2. The number of total days the participant was able to complete the daily diary.

    The rate of completion of daily diary measures, and the number of participants who complete the study in its entirety.

    Time frame: From on-study date through up to 4 months

07

Study locations

1 site
  • St. Jude Children's Research Hospital
    Memphis, Tennessee 38105, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01477255
Lead sponsor
St. Jude Children's Research Hospital
Responsible party
Sponsor
First posted
Nov 22, 2011
Start date
Dec 2011
Primary completion
Mar 2016
Completion
Mar 2016
Last update
Apr 8, 2016

Study contacts

Sean Phipps, PhD
principal investigator · St. Jude Children's Research Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion